SciVision Biotech Inc.
1786
Rank in Stocks
#19150
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid... SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.
Share Price
$1.55
Last synced: 2026-11-10
Market Cap
$113.24M
Change (1 day)
-0.39%
Change (1 year)
-41.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SciVision Biotech Inc. (1786)
Category
Healthcare
Operating Margin for SciVision Biotech Inc. (1786)
Operating Margin as of November 2026 TTM: 16.46%
According to SciVision Biotech Inc.'s latest financial reports, its current operating margin (TTM) is 16.46%. At the end of 2025 the company had an operating margin of 21.42%.
Operating Margin history for SciVision Biotech Inc. from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 16.46% | -23.16% |
| 2025 | 21.42% | -23.75% |
| 2024 | 28.09% | 0.32% |
| 2023 | 28.00% | -11.45% |
| 2022 | 31.62% | 28.64% |
| 2021 | 24.58% | -29.12% |
| 2020 | 34.68% | 7.94% |
| 2019 | 32.13% | 31.30% |
| 2018 | 24.47% | 135.51% |
| 2017 | 10.39% | -191.22% |
| 2016 | -11.39% | -164.17% |
| 2015 | 17.75% | -226.97% |
| 2014 | -13.98% | -189.27% |
| 2013 | 15.66% | -37.96% |
| 2012 | 25.24% | -16.81% |
| 2011 | 30.34% | -259.10% |
| 2010 | -19.07% | -94.13% |
| 2009 | -324.95% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -99.07% |
US
|
|
| 18.08% | -98.90% |
IE
|
|
| 21.25% | -98.71% |
US
|
|
| 21.05% | -98.72% |
US
|
|
| 28.09% | -98.29% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SciVision Biotech Inc.'s operating margin
What is SciVision Biotech Inc.'s operating margin?
SciVision Biotech Inc.'s operating margin is 16.46%, as of Nov 2026.
What was SciVision Biotech Inc.'s operating margin in 2025?
In 2025, SciVision Biotech Inc.'s operating margin was 21.42%, compared with 28.09% in 2024.
How has SciVision Biotech Inc.'s operating margin changed since 2020?
From 2020 to 2025, SciVision Biotech Inc.'s operating margin was highest in 2020 (34.68%) and lowest in 2025 (21.42%).
How does SciVision Biotech Inc.'s operating margin compare with similar companies?
SciVision Biotech Inc.'s operating margin (16.46%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.